ABEO stock news

The holiday-shortened week saw a few huge moves by individual stocks. Abeona Therapeutics Inc (NASDAQ: ABEO) was among the biggest gainers after the … Read more
Clinical-stage biopharma companies often face the risk of running out of cash reserves to fund their operations until they can push their investigational assets out of the clinics and into the commercialization stage. Earlier this week, Abeona Therapeutics Inc (NASDAQ: ABEO ) opted to explore strategic options, and another biotech has now made a similar announcement. What Happened Zafgen Inc (NASDAQ: ZFGN ), a micro-cap biopharma, announced Thursday that it plans to explore strategic options to maximize shareholder value. The strategic alternatives being evaluated include an acquisition, merger, business combination, in-licensing or other strategic transaction involving the company and its … Full story available on Benzinga.com Read more
Investors need to pay close attention to Abeona Therapeutics (ABEO) stock based on the movements in the options market lately. Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 27) Castle Biosciences Inc (NASDAQ: CSTL ) The Medicines Company (NASDAQ: MDCO ) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 27) Abeona Therapeutics Inc (NASDAQ: ABEO ) Advaxis, Inc. (NASDAQ: ADXS ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Alder Biopharmaceuticals Inc (NASDAQ: ALDR ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alimera Sciences Inc (NASDAQ: ALIM ) AnaptysBio Inc (NASDAQ: ANAB ) ASLAN PHARMACEU/ADR (NASDAQ: ASLN ) Assembly Biosciences Inc (NASDAQ: ASMB ) Cancer Genetics Inc (NASDAQ: CGIX ) Catalyst Biosciences Inc (NASDAQ: CBIO ) Clearside Biomedical Inc (NASDAQ: CLSD ) Crinetics Pharmaceuticals Inc (NASDAQ: CRNX ) DelMar Pharmaceuticals Inc (NASDAQ: DMPI )(announced that its current cash position will be sufficient to complete enrollment in all three patient groups of its two ongoing Phase 2 trials for its lead compound VAL-083, which is likely to occur by the fourth quarter of 2020) ICU Medical, Incorporated (NASDAQ: ICUI ) Kala Pharmaceuticals Inc (NASDAQ: KALA ) Mallinckrodt PLC (NYSE: MNK )(reacted to an unfavorable ruling on a patent infringement lawsuit regarding its inhaled nitric oxide product) Neuralstem, Inc. (NASDAQ: CUR ) Novus Therapeutics Inc (NASDAQ: NVUS ) Obalon Therapeutics Inc (NASDAQ: OBLN ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Regenxbio Inc (NASDAQ: RGNX ) Revance Therapeutics Inc (NASDAQ: RVNC )(announced an amended agreement with Mylan NV (NASDAQ: MYL ), … Read more
If you own shares in Abeona Therapeutics Inc. (NASDAQ:ABEO) then it's worth thinking about how it contributes to the… Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 21) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) AstraZeneca plc (NYSE: AZN )(advanced despite reporting negative results for its lung cancer drug) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Cardiovascular Systems Inc (NASDAQ: CSII ) DexCom, Inc. (NASDAQ: DXCM ) Lipocine Inc (NASDAQ: LPCN ) NextCure Inc (NASDAQ: NXTC ) Nevro Corp (NYSE: NVRO ) Novocure Ltd (NASDAQ: NVCR ) Recro Pharma Inc (NASDAQ: REPH ) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 21) Abeona Therapeutics Inc (NASDAQ: ABEO ) Artelo Biosciences Inc (NASDAQ: ARTL ) Avanos Medical Inc (NYSE: AVNS ) CAN-FITE BIOPHA/S ADR (NYSE: CANF ) KemPharm Inc (NASDAQ: KMPH ) Meridian Bioscience, Inc. (NASDAQ: VIVO ) Nektar Therapeutics (NASDAQ:NKT) Obalon Therapeutics Inc (NASDAQ: OBLN ) STRATA Skin Sciences Inc (NASDAQ: SSKN ) Stocks In Focus ViiV's Long-Acting HIV Drug Combo Aces Late-Stage Trial ViiV Healthcare, majority owned by GlaxoSmithKline plc (NYSE: GSK ), with Pfizer Inc. Read more
Abeona Therapeutics (ABEO) delivered earnings and revenue surprises of -25.64% and -100.00%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock? Read more
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 6) Allakos Inc (NASDAQ: ALLK )(announced common stock offering) Cytokinetics, Inc. (NASDAQ: CYTK ) Insulet Corporation (NASDAQ: PODD )( reacted to forecast-beating second-quarter results) Fulgent Genetics Inc (NASDAQ: FLGT )(moved in reaction to second-quarter earnings) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 6) Abeona Therapeutics Inc (NASDAQ: ABEO ) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO ) Alpine Immune Sciences Inc (NASDAQ: ALPN ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM )(reacted to second-quarter results) Bicycle Therapeutics PLC (NASDAQ: BCYC ) BIOLINERX LTD/S ADR (NASDAQ: BLRX )(reacted to second-quarter results) CELLECT BIOTECH/S ADR (NASDAQ: APOP ) ChemoCentryx Inc (NASDAQ: CCXI )(reported below-consensus second-quarter revenues) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Endo International PLC (NASDAQ: ENDP )(reacted to second-quarter results) Equillium Inc (NASDAQ: EQ ) Evogene Ltd (NASDAQ: EVGN ) Hepion Pharmaceuticals Inc (NASDAQ: HEPA ) Innovate Biopharmaceuticals Inc (NASDAQ: INNT ) MEI Pharma Inc (NASDAQ: MEIP ) Merit Medical Systems, Inc. Read more
Abeona Therapeutics (ABEO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 25) Akero Therapeutics Inc (NASDAQ: AKRO ) Anika Therapeutics Inc (NASDAQ: ANIK )( reported better-than-expected second-quarter results) Novocure Ltd (NASDAQ: NVCR )(reported strong second-quarter results) Repligen Corporation (NASDAQ: RGEN ) Xenetic Biosciences Inc (NASDAQ: XBIO ) Baxter International Inc (NYSE: BAX ) (reacted to strong second-quarter results) West Pharmaceutical Services Inc. (NYSE: WST ) (reacted to strong second-quarter results) Myovant Sciences Ltd (NYSE: MYOV ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 25) Abeona Therapeutics Inc (NASDAQ: ABEO )(announced results from a Phase 1/2 trial of its ABO-102, its gene therapy candidate for San Filippo syndrome Type A) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP )(announced initiation of trial dubbed SPEARHEAD-1 that is evaluating ADP-A2M4 SPEAR T cells for patients with synovial sarcoma or myxoid/round cell liposarcoma) Aduro BioTech Inc (NASDAQ: ADRO ) Alkermes Plc (NASDAQ: ALKS )(reacted to Q2 results) Alterity Therapeutics Ltd (NASDAQ: ATHE ) Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL ) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) Aquestive Therapeutics Inc (NASDAQ: AQST ) Assembly Biosciences Inc (NASDAQ: ASMB ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) BENITEC BIOPHAR/S ADR (NASDAQ: BNTC ) ChemoCentryx Inc (NASDAQ: CCXI ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Foamix Pharmaceuticals Ltd (NASDAQ: FOMX ) Gamida Cell Ltd (NASDAQ: GMDA ) GENFIT S A/ADR (NASDAQ: GNFT ) Innoviva Inc (NASDAQ: INVA )(reported below-consensus second-quarter results) Intercept Pharmaceuticals Inc (NASDAQ: ICPT ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA ) Neon Therapeutics Inc (NASDAQ: … Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 23) Akero Therapeutics Inc (NASDAQ: AKRO ) Mirum Pharmaceuticals Inc (NASDAQ: MIRM )( IPOed June 18) Salarius Pharmaceuticals Inc (NASDAQ: SLRX ) VolitionRX Ltd (NYSE: VNRX ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 23) Abbott Laboratories (NYSE: ABT ) Abeona Therapeutics Inc (NASDAQ: ABEO ) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) Advaxis, Inc. (NASDAQ: ADXS )(announced pricing of its 9.2 million common stock offering) Aerie Pharmaceuticals Inc (NASDAQ: AERI ) Apollo Endosurgery Inc (NASDAQ: APEN )(slipped ahead of earnings) Applied DNA Sciences Inc (NASDAQ: APDN ) Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) BIOLINERX LTD/S ADR (NASDAQ: BLRX ) Cancer Genetics Inc (NASDAQ: CGIX ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Foamix Pharmaceuticals Ltd (NASDAQ: FOMX ) Gamida Cell Ltd (NASDAQ: GMDA ) GENFIT S A/ADR (NASDAQ: GNFT ) Heat Biologics Inc (NASDAQ: HTBX ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) Intra-Cellular Therapies Inc (NASDAQ: ITCI ) Invivo Therapeutics Holdings Corp (NASDAQ: NVIV ) Jaguar Health Inc (NASDAQ: JAGX ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Kindred Biosciences Inc (NASDAQ: KIN ) Marinus Pharmaceuticals Inc (NASDAQ: MRNS )( announced data from a late-stage study of postpartum depression drug) MEI Pharma Inc (NASDAQ: MEIP ) ) Myovant Sciences Ltd (NYSE: MYOV )(announced positive late-stage trial results for drug to treat uterine fibroids and heavy menstrual bleeding) Neon Therapeutics Inc (NASDAQ: NTGN ) Neovasc Inc (NASDAQ: NVCN ) Organogenesis Holdings Inc (NASDAQ: ORGO ) Psychemedics Corp. Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 10) CONMED Corporation (NASDAQ: CNMD ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Enlivex Therapeutics Ltd (NASDAQ: ENLV ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Penumbra Inc (NYSE: PEN ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 10) Abeona Therapeutics Inc (NASDAQ: ABEO ) Amneal Pharmaceuticals Inc (NYSE: AMRX ) ( announced a restructuring plan, and also reduced full-year adjusted EBITDA guidance) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Jaguar Health Inc (NASDAQ: JAGX ) VERONA PHARMA P/S ADR (NASDAQ: VRNA ) See Also: Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates Stocks In Focus Neurocrine Says FDA Accepts Regulatory Filing For Parkinson's Drug Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) said the FDA has accepted its NDA for opicapone, a once-daily, oral, selective catechol-O-methyltransferase inhibitor as an adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease … Read more
It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that… Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 20) Abbott Laboratories (NYSE: ABT ) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) argenx SE – ADR (NASDAQ: ARGX ) ArQule, Inc. (NASDAQ: ARQL ) Celgene Corporation (NASDAQ: CELG ) Coherus Biosciences Inc (NASDAQ: CHRS ) DiaMedica Therapeutics Inc (NASDAQ: DMAC )( reported positive interim results from a Phase 1b study of its DM199, which is being evaluated for moderate-to-severe chronic kidney disease) Edesa Biotech Inc (NASDAQ: EDSA )(FDA gave the go ahead to start a Phase 2b trial for EB01, its lead candidate being evaluated for chronic allergic contact dermatitis) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Hologic, Inc. (NASDAQ: HOLX ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech stocks hitting 52-week lows on June 20) Abeona Therapeutics Inc (NASDAQ: ABEO ) Adial Pharmaceuticals Inc (NASDAQ: ADIL ) AMAG Pharmaceuticals, Inc. Read more
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 19) Abbott Laboratories (NYSE: ABT ) CareDx Inc (NASDAQ: CDNA ) CONMED Corporation (NASDAQ: CNMD ) DENTSPLY SIRONA Inc (NASDAQ: XRAY ) Hologic, Inc. (NASDAQ: HOLX ) Insulet Corporation (NASDAQ: PODD ) Merck & Co., Inc. (NYSE: MRK )(reports suggested that the company is on the look out to find a replacement for its CEO Ken Frazier) Novocure Ltd (NASDAQ: NVCR ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc. (NYSE: RMD ) ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) Zynex Inc. (NASDAQ: ZYXI ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech stocks hitting 52-week lows on June 19) Abeona Therapeutics Inc (NASDAQ: ABEO ) CELYAD SA/ADR (NASDAQ: CYAD ) ContraVir Pharmaceuticals Inc (NASDAQ: CTRV ) Jaguar Health Inc (NASDAQ: JAGX ) Spring Bank Pharmaceuticals Inc (NASDAQ: SBPH ) Surface Oncology Inc (NASDAQ: SURF ) Stocks In Focus DiaMedica Drug Found Safe And Effective Against Chronic Kidney Disease DiaMedica Therapeutics Inc (NASDAQ: DMAC ) announced interim results from the Phase 1b study of its DM199, which is being evaluated for moderate-to-severe chronic … Read more

Proudly made at

ROCKIT